Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $7.03B |
| FY2017, ended Dec 30, 2017 | $11.8B |
| FY2018, ended Dec 29, 2018 | $12.2B |
| FY2019, ended Dec 28, 2019 | $19.7B |
| FY2020, ended Jan 2, 2021 | $38.1B |
| FY2021, ended Jan 1, 2022 | $51.7B |
| FY2022, ended Dec 31, 2022 | $43.8B |
| FY2023, ended Dec 31, 2023 | $74.1B |
| FY2024, ended Dec 31, 2024 | $82.4B |
| FY2025, ended Dec 31, 2025 | $85.2B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $90.6B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $1.82B |
| FY2017, ended Dec 30, 2017 | $1.94B |
| FY2018, ended Dec 29, 2018 | $2.14B |
| FY2019, ended Dec 28, 2019 | $2.34B |
| FY2020, ended Jan 2, 2021 | $2.68B |
| FY2021, ended Jan 1, 2022 | $2.99B |
| FY2022, ended Dec 31, 2022 | $3.56B |
| FY2023, ended Dec 31, 2023 | $4.09B |
| FY2024, ended Dec 31, 2024 | $4.64B |
| FY2025, ended Dec 31, 2025 | $5.30B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $6.13B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $203M | $391M |
| FY2017, ended Dec 30, 2017 | $204M | $413M |
| FY2018, ended Dec 29, 2018 | $346M | $543M |
| FY2019, ended Dec 28, 2019 | $989M | $655M |
| FY2020, ended Jan 2, 2021 | $591M | $810M |
| FY2021, ended Jan 1, 2022 | $696M | $1.04B |
| FY2022, ended Dec 31, 2022 | $849M | $1.12B |
| FY2023, ended Dec 31, 2023 | $1.04B | $1.25B |
| FY2024, ended Dec 31, 2024 | $1.06B | $1.12B |
| FY2025, ended Dec 31, 2025 | $1.11B | $1.59B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.38B | $1.76B |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $465M |
| FY2017, ended Dec 30, 2017 | $688M |
| FY2018, ended Dec 29, 2018 | $533M |
| FY2019, ended Dec 28, 2019 | $705M |
| FY2020, ended Jan 2, 2021 | $928M |
| FY2021, ended Jan 1, 2022 | $1.09B |
| FY2022, ended Dec 31, 2022 | $882M |
| FY2023, ended Dec 31, 2023 | $1.01B |
| FY2024, ended Dec 31, 2024 | $2.64B |
| FY2025, ended Dec 31, 2025 | $3.00B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.45B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | — |
| FY2017, ended Dec 30, 2017 | $0 |
| FY2018, ended Dec 29, 2018 | — |
| FY2019, ended Dec 28, 2019 | — |
| FY2020, ended Jan 2, 2021 | — |
| FY2021, ended Jan 1, 2022 | — |
| FY2022, ended Dec 31, 2022 | — |
| FY2023, ended Dec 31, 2023 | — |
| FY2024, ended Dec 31, 2024 | — |
| FY2025, ended Dec 31, 2025 | $2.48B |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $2.48B |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 1.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 279M |
| FY2017, ended Dec 30, 2017 | 283M |
| FY2018, ended Dec 29, 2018 | 280M |
| FY2019, ended Dec 28, 2019 | 280M |
| FY2020, ended Jan 2, 2021 | 279M |
| FY2021, ended Jan 1, 2022 | 277M |
| FY2022, ended Dec 31, 2022 | 273M |
| FY2023, ended Dec 31, 2023 | 272M |
| FY2024, ended Dec 31, 2024 | 274M |
| FY2025, ended Dec 31, 2025 | 273M |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | 274M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees | Sold for cash | Used in acquisitions |
|---|---|---|---|---|
| FY2016, ended Dec 31, 2016 | $960M | $109M | $55.4M | — |
| FY2017, ended Dec 30, 2017 | $100M | $130M | $49.0M | — |
| FY2018, ended Dec 29, 2018 | $250M | $168M | $40.9M | — |
| FY2019, ended Dec 28, 2019 | $306M | $182M | $52.8M | — |
| FY2020, ended Jan 2, 2021 | $380M | $197M | $74.8M | — |
| FY2021, ended Jan 1, 2022 | $612M | $210M | $87.8M | — |
| FY2022, ended Dec 31, 2022 | $1.05B | $270M | $105M | — |
| FY2023, ended Dec 31, 2023 | $700M | $326M | $133M | — |
| FY2024, ended Dec 31, 2024 | $550M | $391M | $204M | $502M |
| FY2025, ended Dec 31, 2025 | $925M | $455M | $146M | — |
| Trailing 12 months to Sep 30, 2026 (through Q3 FY2026) | $1.00B | $543M | $147M | — |
Valuation
At current price- Market Cap
- $94.1B
- P/E
- 68.2×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 15.4×
- Price / Book
- 13.7×
- EV / EBITDA
- 44.1×
Growth
Trailing 12 months- Revenue (TTM)
- $6.13B
- Revenue Growth YoY
- 17.6%
- Revenue CAGR 3Y
- 14.1%
- Revenue CAGR 5Y
- 14.6%
- EPS Growth YoY
- 29.6%
- Net Income Growth YoY
- 30.1%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- 28.9%
- Net Margin
- 22.5%
- FCF Margin
- 28.8%
- Return on Equity
- 22.9%
Earnings
Trailing 12 months- Net Income
- $1.38B
- EPS (diluted)
- $5.03
- EBITDA
- $2.16B
- Operating Income
- $1.77B
Balance Sheet
As of Sep 30, 2026- Cash and cash equivalents
- $1.45B
- Total Debt
- $2.48B
- Net Debt
- $1.03B
- Total Assets
- $12.2B
- Total Liabilities
- $5.35B
- Shareholders' Equity
- $6.88B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $1.97B
- Capital Expenditure
- $204M
- Free Cash Flow
- $1.76B
Dividends and risk
Last 12 months- Dividend Yield
- 0.0%
- Dividend / Share
- $0.00
- Beta (5Y)
- 1.13
Every ratio is calculated from the company’s reported figures.